Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:43:41 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



News for U:APDN from 2025-02-07 to 2026-02-06 - 21 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-10-06 08:00U:APDNNews ReleaseApplied DNA Sciences to Begin Trading Under New Ticker 'BNBX' Reflecting Digital Asset Treasury Strategy
2025-09-29 15:08U:APDNNews ReleaseApplied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation
2025-09-23 08:30U:APDNNews ReleaseApplied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences
2025-08-14 16:10U:APDNNews ReleaseApplied DNA Reports Third Quarter Fiscal 2025 Financial Results
2025-07-24 09:00U:APDNNews ReleaseApplied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application
2025-07-07 09:00U:APDNNews ReleaseApplied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
2025-06-30 09:00U:APDNNews ReleaseApplied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
2025-06-17 16:10U:APDNNews ReleaseApplied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
2025-06-16 09:00U:APDNNews ReleaseApplied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
2025-05-29 16:05U:APDNNews ReleaseApplied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
2025-05-29 08:00U:APDNNews ReleaseApplied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025
2025-05-15 16:07U:APDNNews ReleaseApplied DNA Reports Second Quarter Fiscal 2025 Financial Results
2025-05-14 11:31U:APDNNews ReleaseApplied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
2025-04-21 09:02U:APDNNews ReleaseApplied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
2025-04-08 09:03U:APDNNews ReleaseApplied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
2025-04-01 09:46U:APDNNews ReleaseApplied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
2025-03-26 09:02U:APDNNews ReleaseApplied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
2025-03-12 08:05U:APDNNews ReleaseApplied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
2025-02-13 16:05U:APDNNews ReleaseApplied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
2025-02-12 12:02U:APDNNews ReleaseApplied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
2025-02-11 08:33U:APDNNews ReleaseApplied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14